Home Market News Micro Cap Stocks Massive Surge in RayzeBio Stock Leaves Investors Shaken

Massive Surge in RayzeBio Stock Leaves Investors Shaken

0
Massive Surge in RayzeBio Stock Leaves Investors Shaken

RayzeBio, Inc. RYZB found itself skyrocketing to dizzying heights on Tuesday after the news of its acquisition by Bristol Myers Squibb for $62.50 per share in cash. This earth-shattering deal is valued at $4.1 billion – a hefty chunk of change by anyone’s standards.

On Tuesday, RayzeBio shares rocketed up by a staggering 100% to reach $61.38, leaving both investors and industry analysts stunned by the sudden leap.

The stock market was abuzz with other notable upswings as well.

Winners

  • ARB IOT Group Limited ARBB saw a colossal 270% surge, reaching $3.4850 after already gaining 18% on Friday.
  • IMAC Holdings, Inc. BACK witnessed a remarkable 108% jump to $5.05, following a 53% increase on Friday.
  • Inspira Technologies Oxy B.H.N. Ltd. IINN shot up by 75% to $2.0988 after announcing 95% accuracy for the HYLA blood sensor.
  • Gracell Biotechnologies Inc. GRCL experienced a substantial 60.3% increase, reaching $9.92 following AstraZeneca’s plans to acquire Gracell Biotechnologies for up to $1.2 billion.
  • Science 37 Holdings, Inc. SNCE leaped 52% to $6.62 after receiving notification from Nasdaq that the company had regained compliance with the minimum closing bid price requirement for continued listing.
  • Volcon, Inc. VLCN rose a substantial 49.8% to $0.1483, following a 24% increase on Friday.
  • Sight Sciences, Inc. SGHT gained 48.9% to $5.42.
  • AERWINS Technologies Inc.AWIN surged by 36.4% to $0.1637 after entering into a letter of intent to form an entity with Helicopter Technology, with 70% ownership for AERWINS Technologies Inc. and 30% for Helicopter Technology.
  • SCWorx Corp. WORX climbed 32% to $2.3349 following the announcement of a definitive agreement and plan of merger with American Environmental Partners.
  • 60 Degrees Pharmaceuticals, Inc. SXTP rose 30% to $1.1750 after announcing IRB approval for its Phase IIA clinical study to evaluate tafenoquine for babesiosis.

Carnage on the Market Floor: Investors Left Spinning as Stocks Take a Dive

  • Prospector Capital Corp. LDTC shares fell 30.3% to $2.9218 after jumping around 77% on Friday.
  • NextPlay Technologies, Inc. NXTP shares fell 23.8% to $2.08 after surging over 200% on Friday.
  • ENDRA Life Sciences Inc. NDRA fell 23.6% to $1.91.
  • Esports Entertainment Group, Inc. GMBL dipped 23.6% to $5.28.
  • Banzai International, Inc. BNZI declined 20.7% to $2.75.
  • Adit EdTech Acquisition Corp. ADEX shares fell 20.6% to $3.9801. Adit EdTech Acquisition announced intention to voluntarily de-list from NYSE American.
  • Know Labs, Inc. KNW dipped 19.2% to $0.47. Know Labs filed for mixed shelf of up to $18 million.
  • Turbo Energy, S.A. TURB fell 19% to $1.23.
  • Starbox Group Holdings Ltd. STBX declined 16.2% to $0.2599.
  • Jin Medical International Ltd. ZJYL fell 15.7% to $116.94 after jumping 94% on Friday.
  • ZIM Integrated Shipping Services Ltd. ZIM declined 15.2% to $9.82.
  • Vroom, Inc. VRM shares fell 14.5% to $0.6295. Vroom filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to be held on Feb. 5, 2024 to effect a reverse stock split of the company’s common stock at an exchange ratio between 1-for-35 to 1-for-80.
  • NeoVolta Inc. NEOV fell 14.4% to $1.54.
  • Journey Medical Corporation DERM dipped 13.8% to $6.86.
  • Asset Entities Inc. ASST fell 13.4% to $0.6907 after surging 21% on Friday.
  • Enlivex Therapeutics Ltd. ENLV fell 11% to $2.57.
  • FlexShopper, Inc. FPAY fell 9.5% to $1.6191.
  • BTC Digital Ltd. BTCT fell 9.3% to $4.08. BTC Digital announced entry into $1.014 million share subscription agreements in connection with private placement of ordinary shares for the issue and sale of 303,497 ordinary shares of the company, par value $0.06 per share.
  • Oncternal Therapeutics, Inc. ONCT fell 8% to $0.55. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.
  • Gannett Co., Inc. GCI fell 6.2% to $2.43.

Now Read This: How To Earn $500 A Month From Nike Stock Following Quarterly Report